What's happened
Vivani Medical is developing a long-acting semaglutide implant for GLP-1 therapy to improve adherence and reduce weight regain, with Novo Nordisk partnering to evaluate the device. The tech seeks to deliver drug slowly over months, potentially replacing frequent injections.
What's behind the headline?
What this means for patients and doctors
- The implant could simplify ongoing treatment by reducing dosing frequency.
- It faces questions about long-term effectiveness, tolerance, and insurance coverage.
- Clinicians are wary but cautiously optimistic, seeking robust data before widespread adoption.
Forecast
- If proven safe and effective, the device could shift maintenance strategies for obesity and diabetes care, potentially expanding access and adherence.
- Costs and reimbursement will be pivotal in determining uptake.
Context
- This is part of a broader push to move GLP-1 therapies from pills and injections to long-acting devices, aiming to lower discontinuation rates and sustain weight management.
How we got here
The initiative follows rising dropout rates from GLP-1 therapies due to side effects, costs, and fatigue. Vivani envisions patients starting with injections to reach an effective dose, then switching to the implant for maintenance, with trials and regulatory hurdles ahead.
Our analysis
Novo Nordisk has confirmed the partnership with Vivani and emphasizes complementing internal R&D with external innovation. Independent clinicians stress the need for comparative data against existing regimens to justify adoption. The article cites industry interviews and company statements.
Go deeper
- Will patients prefer an implant over daily or weekly injections?
- How will insurers price and cover the implant if approved?
- What long-term safety data will be required before widespread use?
More on these topics
-
United States - Country in North America
The United States of America, commonly known as the United States or America, is a country mostly located in central North America, between Canada and Mexico.
-
Pfizer - Pharmaceutical company
Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies.